Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 7Terminated 3Recruiting 3Unknown 2

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1Sarcoma 1Other hematologic neoplasm 1Myeloid 1Gastrointestinal 1

Conditions

Gastrointestinal Stromal Tumors 8Neoplasms 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Leukemia 2Hematologic Neoplasms 2Triple Negative Breast Neoplasms 1Solid Tumor Cancer 1Rare Tumor 1Rare Malignant Neoplasm 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myeloproliferative Disorders 1Melanoma 1Lymphangioleiomyomatosis 1Leukemia, Myeloid, Chronic-Phase 1Digestive System Neoplasms 1Congenital Bone Marrow Failure Syndromes 1Burkitt Lymphoma 1Breast Neoplasms 1Blast Crisis 1

Interventions

Blood Specimen Collection 38pembrolizumab 36Bevacizumab 22Surveys and Questionnaires 18Standard of Care 18Radiotherapy 18Exercise 17Carboplatin 16Nivolumab 15atezolizumab 14Cisplatin 14Drug Therapy 13Paclitaxel 12Fluorouracil 12Cyclophosphamide 12Cetuximab 12Trastuzumab 10Leucovorin 10Docetaxel 10Dexamethasone 10Pemetrexed 9Oxaliplatin 9Biopsy 9pertuzumab 8olaparib 8Temozolomide 8Panitumumab 8Observation 8Irinotecan 8abemaciclib 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Neoplasms × Imatinib Mesylate × Clear all
NCT05152472 2026-04-24

ATEZOGIST

Centre Leon Berard

Phase 2 Recruiting
110 enrolled
GastrointestinalSarcoma

Neoplasms, Gastrointestinal Stromal Tumors

NCT05282108 2025-03-26

CARCML

Hikma Pharmaceuticals LLC

Recruiting
240 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Neoplasms, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Hematologic Neoplasms

NCT05467189 2022-07-20

Antineoplastic Drugs in Elderly Patients

Shandong University

Recruiting
500 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡